Effectiveness of skin cancer screening programmes

British Journal of Dermatology

Volumn 167, Issue SUPPL. 2, 2012, Pages 94-98

  Choudhury, K ^a   Volkmer, B ^a,b   Greinert, R ^a,b   Christophers, E ^a   Breitbart, E W ^a,b  

^a Association of Dermatological Prevention   (Germany)

^b Elbekliniken Buxtehude   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; EARLY DIAGNOSIS; GERMANY; HEALTH PROGRAM; HUMAN; MASS SCREENING; MELANOMA; NON MELANOMA SKIN CANCER; PILOT STUDY; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MIDDLE AGED; MORTALITY; SKIN NEOPLASMS; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84864995348     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11091.x     Document Type: Review

References (31)

1. World Health Organization. How Common is Skin Cancer?. 2012. Available at: http://www.who.int/uv/faq/skincancer/en/index1.html (last accessed 30 April 2012).
2. Wilson JMG, Jungner G,. Principles and Practice of Screening for Disease. Geneva: World Health Organization, 1968.
3. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer, 2010.
4. Cancer Research UK. Skin Cancer-UK Incidence Statistics. 2011. Available at: http://info.cancerresearchuk.org/cancerstats/types/skin/incidence/uk-skin- cancer-incidence-statistics (last accessed 30 April 2012).
5. Diepgen TL, Mahler V,. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (Suppl 61): 1-6.
6. de Vries E, Coebergh JW,. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40: 2355-66.
7. de Vries E, Coebergh JW,. Melanoma incidence has risen in Europe. BMJ 2005; 331: 698.
8. Garbe C, Leiter U,. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
9. de Vries E, van de Poll-Franse LV, Louwman WJ, et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152: 481-8.
10. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Sydney: Cancer Council Australia, 2008.
11. Boyle P, Dore JF, Autier P, Ringborg U,. Cancer of the skin: a forgotten problem in Europe. Ann Oncol 2004; 15: 5-6.
12. American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society, 2009.
13. Hakama M, Chamberlain J, Day NE, et al. Evaluation of screening programmes for gynaecological cancer. Br J Cancer 1985; 52: 669-73.
14. World Health Organization. National Cancer Control Programmes: Policies and Managerial Guidelines, 2nd edn. Geneva: World Health Organization, 2002.
15. Wolff T, Tai E, Miller T,. Screening for Skin Cancer: an Update of the Evidence for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
16. Aitken JF, Elwood JM, Lowe JB, et al. A randomised trial of population screening for melanoma. J Med Screen 2002; 9: 33-7.
17. From L, Marrett L, Rosen C, et al. Screening for Skin Cancer: a Clinical Practice Guideline. Toronto, ON: Cancer Care Ontario, 2007.
18. Cancer Council Australia. Position Statement-Screening and Early Detection of Skin Cancer. Sydney: Cancer Council Australia, 2007.
19. U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2009; 150: 188-93.
20. van der Leest RJ, de Vries E, Bulliard JL, et al. The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol Venereol 2011; 25: 1455-65.
21. Geller AC, Swetter SM, Oliveria S, et al. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol 2011; 65: S87-94.
22. Truyers C, Lesaffre E, Kellen E, et al. Malignant melanoma: to screen or not to screen? An evaluation of the Euromelanoma Day in Belgium. Eur J Dermatol 2010; 20: 517-18.
23. Seidenari S, Benati E, Ponti G, et al. Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. Eur J Cancer Prev 2012; 21: 89-95.
24. Paoli J, Danielsson M, Wennberg AM,. Results of the 'Euromelanoma Day' screening campaign in Sweden 2008. J Eur Acad Dermatol Venereol 2009; 23: 1304-10.
25. Husmann G, Kaatsch P, Katalinic A, et al. Krebs in Deutschland 2005/2006. Häufigkeiten und Trends. Saarbrücken, Germany: Robert-Koch-Institut und Gesellschaft der Epidemiologischen Krebsregister in Deutschland, 2010.
26. Krebsregister Schleswig-Holstein. 2010. Available at: http://www.krebsregister-sh.de/krebsregister/index.html (last accessed 30 April 2012).
27. Bundesausschuss G., Richtlinie des Gemeinsamen Bundesausschusses über die Früherkennung von Krebserkrankungen (Krebsfrü herkennungs-Richtlinie/KFE-RL). Bundesanzeiger 2011; 34: 864.
28. Geller AC, Greinert R, Sinclair C, et al. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol 2010; 34: 355-8.
29. Kassenärztliche Bundesvereinigung. Erste Bilanz zum Hautkrebsscreening. 2010. Available at: http://www.kbv.de/presse/26537.html (last accessed 30 April 2012).
30. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201-11.
31. Katalinic A, Waldmann A, Weinstock MA, et al. Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 2012.